Laboratory markers predicting severity of acute pancreatitis

References

• Fagenholz PJ, Castillo CF, Harris NS, et al. Increasing United States hospital admissions for acute pancreatitis, 1988–2003. Ann Epidemiol 2007;17:491–7
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis – 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–11
   PubMed Web of Science ®Google Scholar
• Gloor B, Muller CA, Worni M, et al. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001;88:975–9
   PubMed Web of Science ®Google Scholar
• Banks PA, Freeman ML, Practice Parameters Committee of the American College of G. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379–400
   PubMed Web of Science ®Google Scholar
• Fisher JM, Gardner TB. The “golden hours” of management in acute pancreatitis. Am J Gastroenterol 2012;107:1146–50
   PubMed Web of Science ®Google Scholar
• Tenner S, Baillie J, DeWitt J, Vege SS, American College of G. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013;108:1400–15; 16
   PubMed Web of Science ®Google Scholar
• Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999;25:195–210
   PubMedGoogle Scholar
• Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260–4
   PubMed Web of Science ®Google Scholar
• Robert JH, Frossard JL, Mermillod B, et al. Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glascow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg 2002;26:612–19
   PubMed Web of Science ®Google Scholar
• Schutte K, Malfertheiner P. Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol 2008;22:75–90
   PubMed Web of Science ®Google Scholar
• Gravante G, Garcea G, Ong SL, et al. Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. Pancreatology 2009;9:601–14
   PubMed Web of Science ®Google Scholar
• Gerzof SG, Banks PA, Robbins AH, et al. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology 1987;93:1315–20
   PubMed Web of Science ®Google Scholar
• Trapnell JE. The natural history and prognosis of acute pancreatitis. Ann Roy College Surg Engl 1966;38:265–87
   PubMedGoogle Scholar
• Block S, Maier W, Bittner R, et al. Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut 1986;27:1035–42
   PubMed Web of Science ®Google Scholar
• Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007;245:745–54
   PubMed Web of Science ®Google Scholar
• Al-Bahrani AZ, Ammori BJ. Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta 2005;362:26–48
   PubMed Web of Science ®Google Scholar
• Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg. 1989;762):177–81
   Google Scholar
• Working Group IAPAPAAPG. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013;13:e1–15
   PubMed Web of Science ®Google Scholar
• Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002;89:163–71
   PubMed Web of Science ®Google Scholar
• Rau B, Steinbach G, Baumgart K, et al. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 2000;28:736–42
   PubMed Web of Science ®Google Scholar
• Gurda-Duda A, Kusnierz-Cabala B, Nowak W, et al. Assessment of the prognostic value of certain acute-phase proteins and procalcitonin in the prognosis of acute pancreatitis. Pancreas 2008;37:449–53
   PubMed Web of Science ®Google Scholar
• Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999;180:1584–9
   PubMed Web of Science ®Google Scholar
• Rau B, Steinbach G, Kruger CM, et al. Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Langenbeck Arch Surg/Dtsch Ges Chir 2003;388:181–8
   PubMedGoogle Scholar
• Erwin PJ, Lewis H, Dolan S, et al. Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med 2000;28:104–9
   PubMed Web of Science ®Google Scholar
• Hill AL, Lowes DA, Webster NR, et al. Regulation of pentraxin-3 by antioxidants. Br J Anaesth 2009;103:833–9
   PubMed Web of Science ®Google Scholar
• Kusnierz-Cabala B, Gurda-Duda A, Dumnicka P, et al. Plasma pentraxin 3 concentrations in patients with acute pancreatitis. Clin Lab 2013;59:1003–8
   PubMed Web of Science ®Google Scholar
• Mofidi R, Suttie SA, Patil PV, et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 2009;146:72–81
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metabol 1994;79:1605–8
   PubMed Web of Science ®Google Scholar
• van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 2010;362:1491–502
   PubMed Web of Science ®Google Scholar
• Modrau IS, Floyd AK, Thorlacius-Ussing O. The clinical value of procalcitonin in early assessment of acute pancreatitis. Am J Gastroenterol 2005;100:1593–7
   PubMed Web of Science ®Google Scholar
• Bezmarevic M, Mirkovic D, Soldatovic I, et al. Correlation between procalcitonin and intra-abdominal pressure and their role in prediction of the severity of acute pancreatitis. Pancreatology 2012;12:337–43
   PubMed Web of Science ®Google Scholar
• Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000;47:546–52
   PubMed Web of Science ®Google Scholar
• Rau BM. Predicting severity of acute pancreatitis. Curr Gastroenterol Rep 2007;9:107–15
   PubMedGoogle Scholar
• Zhang J, Niu J, Yang J. Interleukin-6, interleukin-8 and interleukin-10 in estimating the severity of acute pancreatitis: an updated meta-analysis. Hepatogastroenterology 2014;61:215–20
   PubMed Web of Science ®Google Scholar
• Aoun E, Chen J, Reighard D, et al. Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: a meta-analysis. Pancreatology 2009;9:777–85
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Digest Dis Sci 1995;40:2341–8
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993;21:S447–63
   PubMed Web of Science ®Google Scholar
• Malmstrom ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas 2012;41:271–7
   PubMed Web of Science ®Google Scholar
• Shen Y, Cui N, Miao B, Zhao E. Immune dysregulation in patients with severe acute pancreatitis. Inflammation 2011;34:36–42
   PubMed Web of Science ®Google Scholar
• Pooran N, Indaram A, Singh P, Bank S. Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol 2003;37:263–6
   PubMed Web of Science ®Google Scholar
• Panek J, Rembiasz K, Karcz D, et al. Acute biliary pancreatitis in the era of minimally invasive surgery. Adv Med Sci 2006;51:98–102
   PubMedGoogle Scholar
• Surbatovic M, Radakovic S. Tumor necrosis factor-alpha levels early in severe acute pancreatitis: is there predictive value regarding severity and outcome? J Clin Gastroenterol 2013;47:637–43
   PubMed Web of Science ®Google Scholar
• Paajanen H, Laato M, Jaakkola M, et al. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg. 1995;82:271–3
   PubMed Web of Science ®Google Scholar
• Digalakis MK, Katsoulis IE, Biliri K, Themeli-Digalaki K. Serum profiles of C-reactive protein, interleukin-8, and tumor necrosis factor-alpha in patients with acute pancreatitis. HPB Surg 2009;2009:878490
   PubMedGoogle Scholar
• Dambrauskas Z, Giese N, Gulbinas A, et al. Different profiles of cytokine expression during mild and severe acute pancreatitis. World J Gastroenterol 2010;16:1845–53
   PubMed Web of Science ®Google Scholar
• Rahman SH, Menon KV, Holmfield JH, et al. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis. Ann Surg 2007;245:282–9
   PubMed Web of Science ®Google Scholar
• Borgstrom A, Appelros S, Muller CA, et al. Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002;131:125–8
   PubMed Web of Science ®Google Scholar
• Huang QL, Qian ZX, Li H. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis. Hepato-gastroenterol 2010;57:1295–9
   PubMed Web of Science ®Google Scholar
• Chen YT, Chen CC, Wang SS, et al. Rapid urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis. Pancreas 2005;30:243–7
   PubMed Web of Science ®Google Scholar
• Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4–8
   PubMed Web of Science ®Google Scholar
• Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105–10
   PubMedGoogle Scholar
• Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000;355:1955–60
   PubMed Web of Science ®Google Scholar
• Saez J, Martinez J, Trigo C, et al. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World J Gastroenterol 2005;11:7261–5
   PubMed Web of Science ®Google Scholar
• Appelros S, Petersson U, Toh S, et al. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001;88:216–21
   PubMed Web of Science ®Google Scholar
• Muller CA, Appelros S, Uhl W, et al. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002;51:229–35
   PubMed Web of Science ®Google Scholar
• Saez J, Martinez J, Trigo C, et al. A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004;29:e9–14
   PubMed Web of Science ®Google Scholar
• Heath DI, Cruickshank A, Gudgeon AM, et al. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995;10:347–53
   PubMed Web of Science ®Google Scholar
• Rae D, Sumar N, Beechey-Newman N, et al. Type 1-prophospholipase A2 propeptide immunoreactivity is released from activated granulocytes. Clin Biochem 1995;28:71–8
   PubMed Web of Science ®Google Scholar
• Kemppainen E, Hietaranta A, Puolakkainen P, et al. Time course profile of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin in patients with acute pancreatitis. Scand J Gastroenterol 2000;35:1216–20
   PubMed Web of Science ®Google Scholar
• Hedström J, Sainio V, Kemppainen E, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996;313:333–7
   PubMed Web of Science ®Google Scholar
• Lempinen M, Stenman UH, Halttunen J, et al. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography. Pancreatology 2005;5:157–64
   PubMed Web of Science ®Google Scholar
• Bisaro de Lorenc L, Ramos AM, Sanchez MC, et al. Structural evaluation of plasma alpha2-macroglobulin in acute pancreatitis. Clin Chem Lab Med 2005;43:1183–9
   PubMed Web of Science ®Google Scholar
• Banks RE, Evans SW, Alexander D, et al. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut 1991;32:430–4
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Tilz GP, Smolle KH, et al. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis. Immunobiology 1996;195:209–19
   PubMed Web of Science ®Google Scholar
• Dabrowski A, Osada J, Dabrowska MI, et al. Increased expression of the intercellular adhesion molecule-1 (ICAM-1) on peripheral blood neutrophils in acute pancreatitis. Adv Med Sci 2014;59:102–7
   PubMed Web of Science ®Google Scholar
• Zhu HH, Jiang LL. Serum inter-cellular adhesion molecule 1 is an early marker of diagnosis and prediction of severe acute pancreatitis. World J Gastroenterol 2012;18:2554–60
   PubMed Web of Science ®Google Scholar
• Mandi Y, Farkas G, Takacs T, et al. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol 2000;28:41–9
   PubMedGoogle Scholar
• Kylanpaa-Back ML, Takala A, Kemppainen EA, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63–9
   PubMed Web of Science ®Google Scholar
• Wereszczynska-Siemiatkowska U, Dabrowski A, Siemiatkowski A, et al. Serum profiles of E-selectin, interleukin-10, and interleukin-6 and oxidative stress parameters in patients with acute pancreatitis and nonpancreatic acute abdominal pain. Pancreas 2003;26:144–52
   PubMed Web of Science ®Google Scholar
• Powell JJ, Siriwardena AK, Fearon KC, Ross JA. Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med 2001;29:567–72
   PubMed Web of Science ®Google Scholar
• Hynninen M, Valtonen M, Markkanen H, et al. Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care 1999;14:63–8
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Corsi MM, Barassi A, et al. Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severity. Pancreas 2008;37:36–41
   PubMed Web of Science ®Google Scholar
• Abu Hilal M, Ung CT, Westlake S, Johnson CD. Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. J Gastroenterol Hepatol 2007;22:349–54
   PubMed Web of Science ®Google Scholar
• Pittard AJ, Banks RE, Galley HF, Webster NR. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996;76:629–31
   PubMed Web of Science ®Google Scholar
• Sewpaul A, French JJ, Khoo TK, et al. Soluble E-cadherin: an early marker of severity in acute pancreatitis. HPB Surg 2009;2009:397375
   PubMedGoogle Scholar
• Domínguez-Muñoz JE, Carballo F, Garcia MJ, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991;78:1230–4
   PubMed Web of Science ®Google Scholar
• Dominguez-Munoz JE, Villanueva A, Larino J, et al. Accuracy of plasma levels of polymorphonuclear elastase as early prognostic marker of acute pancreatitis in routine clinical conditions. Eur J Gastroenterol Hepatol 2006;18:79–83
   PubMed Web of Science ®Google Scholar
• Berney T, Gasche Y, Robert J, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999;18:371–7
   PubMed Web of Science ®Google Scholar
• Novovic S, Andersen AM, Nord M, et al. Activity of neutrophil elastase reflects the progression of acute pancreatitis. Scand J Clin Lab Invest 2013;73:485–93
   PubMed Web of Science ®Google Scholar
• Friess H, Shrikhande S, Riesle E, et al. Phospholipase A2 isoforms in acute pancreatitis. Ann Surg 2001;233:204–12
   PubMed Web of Science ®Google Scholar
• Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993;34:1133–6
   PubMed Web of Science ®Google Scholar
• Mayer J, Rau B, Grewe M, et al. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 1998;17:272–7
   PubMed Web of Science ®Google Scholar
• Bird NC, Goodman AJ, Johnson AG. Serum phospholipase A2 activity in acute pancreatitis: an early guide to severity. Br J Surg 1989;76:731–2
   PubMed Web of Science ®Google Scholar
• Carroll JK, Herrick B, Gipson T, Lee SP. Acute pancreatitis: diagnosis, prognosis, and treatment. Am Fam Phys 2007;75:1513–20
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Paredes SD, Korkmaz A, et al. Melatonin combats molecular terrorism at the mitochondrial level. Interdiscip Toxicol 2008;1:137–49
   PubMedGoogle Scholar
• Gulben K, Ozdemir H, Berberoglu U, et al. Melatonin modulates the severity of taurocholate-induced acute pancreatitis in the rat. Digest Dis Sci 2010;55:941–6
   PubMed Web of Science ®Google Scholar
• Jin Y, Lin CJ, Dong LM, et al. Clinical significance of melatonin concentrations in predicting the severity of acute pancreatitis. World J Gastroenterol 2013;19:4066–71
   PubMed Web of Science ®Google Scholar
• Whitcomb DC, Muddana V, Langmead CJ, et al. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010;105:2287–92
   PubMed Web of Science ®Google Scholar
• Buddingh KT, Koudstaal LG, van Santvoort HC, et al. Early angiopoietin-2 levels after onset predict the advent of severe pancreatitis, multiple organ failure, and infectious complications in patients with acute pancreatitis. J Am Coll Surg 2014;218:26–32
   PubMed Web of Science ®Google Scholar
• Ohashi S, Nishio A, Nakamura H, et al. Clinical significance of serum thioredoxin 1 levels in patients with acute pancreatitis. Pancreas 2006;32:264–70
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112–19
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Muller B, Struck J, et al. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28:219–26
   PubMed Web of Science ®Google Scholar
• Lin C, Wang N, Shen ZP, Zhao ZY. Plasma copeptin concentration and outcome after pediatric traumatic brain injury. Peptides 2013;42:43–7
   PubMed Web of Science ®Google Scholar
• Kolditz M, Halank M, Schulte-Hubbert B, et al. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Resp Med 2012;106:1320–8
   PubMed Web of Science ®Google Scholar
• Isman FK, Zulfikaroglu B, Isbilen B, et al. Copeptin is a predictive biomarker of severity in acute pancreatitis. Am J Emerg Med 2013;31:690–2
   PubMed Web of Science ®Google Scholar
• Sang G, Du JM, Chen YY, et al. Plasma copeptin levels are associated with prognosis of severe acute pancreatitis. Peptides 2014;51:4–8
   PubMed Web of Science ®Google Scholar
• Lu CW, Liu LC, Hsieh YC, et al. Increased admission serum estradiol level is correlated with high mortality in patients with severe acute pancreatitis. J Gastroenterol 2013;48:374–81
   PubMed Web of Science ®Google Scholar
• Spratt DI, Cox P, Orav J, et al. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metabol 1993;76:1548–54
   PubMed Web of Science ®Google Scholar